vs
福泰制药（VRTX）与Waste Management（WM）财务数据对比。点击上方公司名可切换其他公司
Waste Management的季度营收约是福泰制药的2.0倍（$6.2B vs $3.2B），福泰制药净利率更高（37.3% vs 11.6%，领先25.7%），福泰制药同比增速更快（9.5% vs 3.5%），Waste Management自由现金流更多（$981.0M vs $348.6M），过去两年福泰制药的营收复合增速更高（8.9% vs 7.4%）
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
Waste Management是专业的废弃物管理服务提供商，业务覆盖废弃物从产生到最终处置的全流程，包含垃圾收集、运输、处理、处置等核心环节，同时涉及废弃物管理流程监督、相关法规合规、技术应用及商业机制优化等相关业务。
VRTX vs WM — 直观对比
营收规模更大
WM
是对方的2.0倍
$3.2B
营收增速更快
VRTX
高出6.1%
3.5%
净利率更高
VRTX
高出25.7%
11.6%
自由现金流更多
WM
多$632.4M
$348.6M
两年增速更快
VRTX
近两年复合增速
7.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.2B | $6.2B |
| 净利润 | $1.2B | $723.0M |
| 毛利率 | 85.4% | — |
| 营业利润率 | 37.8% | 17.9% |
| 净利率 | 37.3% | 11.6% |
| 营收同比 | 9.5% | 3.5% |
| 净利润同比 | 30.5% | 13.5% |
| 每股收益（稀释后） | $4.64 | $1.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收VRTXWM
| Q1 26 | — | $6.2B | ||
| Q4 25 | $3.2B | $6.3B | ||
| Q3 25 | $3.1B | $6.4B | ||
| Q2 25 | $3.0B | $6.4B | ||
| Q1 25 | $2.8B | $6.0B | ||
| Q4 24 | $2.9B | $5.9B | ||
| Q3 24 | $2.8B | $5.6B | ||
| Q2 24 | $2.6B | $5.4B |
净利润VRTXWM
| Q1 26 | — | $723.0M | ||
| Q4 25 | $1.2B | $742.0M | ||
| Q3 25 | $1.1B | $603.0M | ||
| Q2 25 | $1.0B | $726.0M | ||
| Q1 25 | $646.3M | $637.0M | ||
| Q4 24 | $913.0M | $598.0M | ||
| Q3 24 | $1.0B | $760.0M | ||
| Q2 24 | $-3.6B | $680.0M |
毛利率VRTXWM
| Q1 26 | — | — | ||
| Q4 25 | 85.4% | 41.5% | ||
| Q3 25 | 86.5% | 40.5% | ||
| Q2 25 | 86.3% | 40.3% | ||
| Q1 25 | 86.9% | 39.4% | ||
| Q4 24 | 85.5% | 39.7% | ||
| Q3 24 | 85.8% | 39.4% | ||
| Q2 24 | 85.9% | 39.1% |
营业利润率VRTXWM
| Q1 26 | — | 17.9% | ||
| Q4 25 | 37.8% | 18.3% | ||
| Q3 25 | 38.6% | 15.3% | ||
| Q2 25 | 38.8% | 17.9% | ||
| Q1 25 | 22.7% | 16.8% | ||
| Q4 24 | 35.2% | 15.6% | ||
| Q3 24 | 40.3% | 20.0% | ||
| Q2 24 | -132.9% | 18.7% |
净利率VRTXWM
| Q1 26 | — | 11.6% | ||
| Q4 25 | 37.3% | 11.8% | ||
| Q3 25 | 35.2% | 9.4% | ||
| Q2 25 | 34.8% | 11.3% | ||
| Q1 25 | 23.3% | 10.6% | ||
| Q4 24 | 31.4% | 10.1% | ||
| Q3 24 | 37.7% | 13.5% | ||
| Q2 24 | -135.8% | 12.6% |
每股收益（稀释后）VRTXWM
| Q1 26 | — | $1.79 | ||
| Q4 25 | $4.64 | $1.83 | ||
| Q3 25 | $4.20 | $1.49 | ||
| Q2 25 | $3.99 | $1.80 | ||
| Q1 25 | $2.49 | $1.58 | ||
| Q4 24 | $3.62 | $1.49 | ||
| Q3 24 | $4.01 | $1.88 | ||
| Q2 24 | $-13.92 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.6B | $158.0M |
| 总债务越低越好 | — | $22.9B |
| 股东权益账面价值 | $18.7B | $10.0B |
| 总资产 | $25.6B | $45.7B |
| 负债/权益比越低杠杆越低 | — | 2.28× |
8季度趋势，按日历期对齐
现金及短期投资VRTXWM
| Q1 26 | — | $158.0M | ||
| Q4 25 | $6.6B | $201.0M | ||
| Q3 25 | $6.3B | $175.0M | ||
| Q2 25 | $6.4B | $440.0M | ||
| Q1 25 | $6.2B | $216.0M | ||
| Q4 24 | $6.1B | $414.0M | ||
| Q3 24 | $6.5B | $614.0M | ||
| Q2 24 | $5.8B | $172.0M |
总债务VRTXWM
| Q1 26 | — | $22.9B | ||
| Q4 25 | — | $22.2B | ||
| Q3 25 | — | $22.5B | ||
| Q2 25 | — | $23.1B | ||
| Q1 25 | — | $22.9B | ||
| Q4 24 | — | $22.5B | ||
| Q3 24 | — | $16.0B | ||
| Q2 24 | — | $16.5B |
股东权益VRTXWM
| Q1 26 | — | $10.0B | ||
| Q4 25 | $18.7B | $10.0B | ||
| Q3 25 | $17.3B | $9.5B | ||
| Q2 25 | $17.2B | $9.2B | ||
| Q1 25 | $16.5B | $8.7B | ||
| Q4 24 | $16.4B | $8.3B | ||
| Q3 24 | $15.6B | $8.0B | ||
| Q2 24 | $14.8B | $7.5B |
总资产VRTXWM
| Q1 26 | — | $45.7B | ||
| Q4 25 | $25.6B | $45.8B | ||
| Q3 25 | $24.9B | $45.6B | ||
| Q2 25 | $24.0B | $45.7B | ||
| Q1 25 | $22.9B | $44.5B | ||
| Q4 24 | $22.5B | $44.6B | ||
| Q3 24 | $22.2B | $34.7B | ||
| Q2 24 | $20.1B | $34.0B |
负债/权益比VRTXWM
| Q1 26 | — | 2.28× | ||
| Q4 25 | — | 2.22× | ||
| Q3 25 | — | 2.36× | ||
| Q2 25 | — | 2.51× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 2.73× | ||
| Q3 24 | — | 2.00× | ||
| Q2 24 | — | 2.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $498.0M | $1.5B |
| 自由现金流经营现金流 - 资本支出 | $348.6M | $981.0M |
| 自由现金流率自由现金流/营收 | 10.9% | 15.8% |
| 资本支出强度资本支出/营收 | 4.7% | — |
| 现金转化率经营现金流/净利润 | 0.42× | 2.08× |
| 过去12个月自由现金流最近4个季度 | $3.2B | $3.4B |
8季度趋势，按日历期对齐
经营现金流VRTXWM
| Q1 26 | — | $1.5B | ||
| Q4 25 | $498.0M | $1.7B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $818.9M | $1.2B | ||
| Q4 24 | $584.6M | $1.5B | ||
| Q3 24 | $1.4B | $1.4B | ||
| Q2 24 | $-3.8B | $1.2B |
自由现金流VRTXWM
| Q1 26 | — | $981.0M | ||
| Q4 25 | $348.6M | $810.0M | ||
| Q3 25 | $1.1B | $816.0M | ||
| Q2 25 | $927.4M | $813.0M | ||
| Q1 25 | $778.2M | $377.0M | ||
| Q4 24 | $492.0M | $396.0M | ||
| Q3 24 | $1.3B | $577.0M | ||
| Q2 24 | $-3.8B | $487.0M |
自由现金流率VRTXWM
| Q1 26 | — | 15.8% | ||
| Q4 25 | 10.9% | 12.8% | ||
| Q3 25 | 37.0% | 12.7% | ||
| Q2 25 | 31.3% | 12.6% | ||
| Q1 25 | 28.1% | 6.3% | ||
| Q4 24 | 16.9% | 6.7% | ||
| Q3 24 | 47.0% | 10.3% | ||
| Q2 24 | -144.5% | 9.0% |
资本支出强度VRTXWM
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 14.1% | ||
| Q3 25 | 3.3% | 12.0% | ||
| Q2 25 | 4.9% | 11.4% | ||
| Q1 25 | 1.5% | 13.8% | ||
| Q4 24 | 3.2% | 18.9% | ||
| Q3 24 | 2.4% | 13.9% | ||
| Q2 24 | 2.6% | 12.3% |
现金转化率VRTXWM
| Q1 26 | — | 2.08× | ||
| Q4 25 | 0.42× | 2.29× | ||
| Q3 25 | 1.15× | 2.64× | ||
| Q2 25 | 1.04× | 2.13× | ||
| Q1 25 | 1.27× | 1.90× | ||
| Q4 24 | 0.64× | 2.53× | ||
| Q3 24 | 1.31× | 1.79× | ||
| Q2 24 | — | 1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
WM
暂无分部数据
